BMY compared with PFE: revenue, margins and what each company keeps, and the suppliers and customers both name

BMYBristol Myers Squibb Co

Mkt capRevenueRevenue

PFEPfizer Inc

Mkt capRevenueRevenue

Compare

BMYBristol Myers Squibb Co

PFEPfizer Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

BMY

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±3.6%▲+1.35%×0.39

Q2 FY26±3.7%▲+2.79%×0.76

Q1 FY26±4.1%▲+5.21%×1.27

Feb 5 '26±3.8%▲+3.30%×0.87

PFE

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±3.3%▲+1.52%×0.45

Q1 FY26±3.5%▲+0.57%×0.17

= impliedBMY realized, solidPFE realized, hatchedOne scale, both sides: full bar = 6%× = |realized| ÷ impliedSource: market data

Feb 3 '26

±3.2%

▼−3.34%

×1.03

Q3 FY25±4.2%▼−1.46%×0.36

BMYBristol Myers Squibb Co

62.52▲+1.85%· post 62.55

Mkt cap$127.7BRevenue$13.1BQ3 FY26Revenue$48.2BFY25

PFEPfizer Inc

30.50▲+1.83%· post 30.46

ClosedOct 30 '26

Mkt cap$174.0BRevenue$15.0BQ2 FY26Revenue$62.6BFY25

Compare

ClosedOct 30 '26

BMYBristol Myers Squibb Co

PFEPfizer Inc

62.52▲+1.85%post 62.55

Price

30.50▲+1.83%post 30.46

$127.7B

Mkt cap

$174.0B

Q3 FY26$13.1B

Revenue

$15.0BQ2 FY26

FY25$48.2B

Revenue

$62.6BFY25

BMY62.52▲+1.85%vsPFE30.50▲+1.83%ClosedOct 30 '26